AAAAAA
Results: 1-25/30
Authors:
THOR AD
BERRY DA
BUDMAN DR
MUSS HB
KUTE T
HENDERSON IC
BARCOS M
CIRRINCIONE C
EDGERTON S
ALLRED C
NORTON L
LIU ET
Citation: Ad. Thor et al., ERBB-2, P53, AND EFFICACY OF ADJUVANT THERAPY IN LYMPH NODE-POSITIVE BREAST-CANCER, Journal of the National Cancer Institute, 90(18), 1998, pp. 1346-1360
Authors:
BUDMAN DR
BERRY DA
CIRRINCIONE CT
HENDERSON IC
WOOD WC
WEISS RB
FERREE CR
MUSS HB
GREEN MR
NORTON L
FREI E
Citation: Dr. Budman et al., DOSE AND DOSE INTENSITY AS DETERMINANTS OF OUTCOME IN THE ADJUVANT TREATMENT OF BREAST-CANCER, Journal of the National Cancer Institute, 90(16), 1998, pp. 1205-1211
Authors:
MUSS HB
Citation: Hb. Muss, UPDATE ON BREAST-CANCER, Annals of oncology, 9, 1998, pp. 42-42
Authors:
KIMMICK GG
FLEMING R
MUSS HB
BALDUCCI L
Citation: Gg. Kimmick et al., CANCER-CHEMOTHERAPY IN OLDER ADULTS - A TOLERABILITY PERSPECTIVE, Drugs & aging, 10(1), 1997, pp. 34-49
Authors:
KIMMICK G
MUSS HB
Citation: G. Kimmick et Hb. Muss, BREAST-CANCER IN OLDER WOMEN, Clinics in geriatric medicine, 13(2), 1997, pp. 265
Authors:
SOMERFIELD MR
SCHAPIRA DV
DAVIDSON NE
BLUMING M
ESSERMAN L
GRUNFELD E
HALBERG FE
HANTEL A
KENNEDY A
MUSS HB
SMITH TJ
VOGEL VG
Citation: Mr. Somerfield et al., RECOMMENDED BREAST-CANCER SURVEILLANCE GUIDELINES (VOL 15, PG 2149, 1997), Journal of clinical oncology, 15(7), 1997, pp. 2762-2762
Authors:
SOMERFIELD MR
SCHAPIRA DV
DAVIDSON NE
BLUMING M
ESSERMAN L
GRUNFELD E
HALBERG FE
HANTEL A
KENNEDY A
MUSS HB
SMITH TJ
VOGEL VG
Citation: Mr. Somerfield et al., RECOMMENDED BREAST-CANCER SURVEILLANCE GUIDELINES, Journal of clinical oncology, 15(5), 1997, pp. 2149-2156
Authors:
KUSS JT
MUSS HB
HOEN H
CASE LD
Citation: Jt. Kuss et al., TAMOXIFEN AS INITIAL ENDOCRINE THERAPY FOR METASTATIC BREAST-CANCER -LONG-TERM FOLLOW-UP OF 2 PIEDMONT-ONCOLOGY-ASSOCIATION (POA) TRIALS, Breast cancer research and treatment, 42(3), 1997, pp. 265-274
Authors:
ROBINSON E
KIMMICK GG
MUSS HB
Citation: E. Robinson et al., TAMOXIFEN IN POSTMENOPAUSAL WOMEN - A SAFETY PERSPECTIVE, Drugs & aging, 8(5), 1996, pp. 329-337
Authors:
FLEMING RA
CAPIZZI RL
MUSS HB
SMITH S
FERNANDES DJ
HOMESLEY H
LOGGIE BW
CASE LD
MORRIS R
RUSSELL GB
RICHARDS F
Citation: Ra. Fleming et al., PHASE-I STUDY OF N-(PHOSPHONACETYL)-L-ASPARTATE WITH FLUOROURACIL ANDWITH OR WITHOUT DIPYRIDAMOLE IN PATIENTS WITH ADVANCED CANCER, Clinical cancer research, 2(7), 1996, pp. 1107-1114
Authors:
PATTON JF
POWELL BL
WHITE DR
RUSSELL GB
INABINET RT
MUSS HB
Citation: Jf. Patton et al., COMBINATION CISPLATIN AND CARBOPLATIN IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Cancer investigation, 14(2), 1996, pp. 98-102
Authors:
ATKINS JN
MUSS HB
CASE LD
RICHARDS F
GROTE T
MCFARLAND J
Citation: Jn. Atkins et al., LEUCOVORIN AND HIGH-DOSE FLUOROURACIL IN METASTATIC PROSTATE-CANCER -A PHASE-II TRIAL OF THE PIEDMONT-ONCOLOGY-ASSOCIATION, American journal of clinical oncology, 19(1), 1996, pp. 23-25
Authors:
MUSS HB
Citation: Hb. Muss, BREAST-CANCER IN OLDER WOMEN, Seminars in oncology, 23(1), 1996, pp. 82-88
Authors:
CURRIE JL
BLESSING JA
MUSS HB
FOWLER J
BERMAN M
BURKE TW
Citation: Jl. Currie et al., COMBINATION CHEMOTHERAPY WITH HYDROXYUREA, DACARBAZINE (DTIC), AND ETOPOSIDE IN THE TREATMENT OF UTERINE LEIOMYOSARCOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 61(1), 1996, pp. 27-30
Authors:
MAYBERRY RM
COATES RJ
HILL HA
CLICK LA
CHEN VW
AUSTIN DF
REDMOND CK
FENOGLIOPREISER CM
HUNTER CP
HAYNES MA
MUSS HB
WESLEY MN
GREENBERG RS
EDWARDS BK
Citation: Rm. Mayberry et al., DETERMINANTS OF BLACK-WHITE DIFFERENCES IN COLON-CANCER SURVIVAL, Journal of the National Cancer Institute, 87(22), 1995, pp. 1686-1693
Authors:
MCQUELLON RP
MUSS HB
HOFFMAN SL
RUSSELL G
CRAVEN B
YELLEN SB
Citation: Rp. Mcquellon et al., PATIENT PREFERENCES FOR TREATMENT OF METASTATIC BREAST-CANCER - A STUDY OF WOMEN WITH EARLY-STAGE BREAST-CANCER, Journal of clinical oncology, 13(4), 1995, pp. 858-868
Authors:
LOOK KY
MUSS HB
BLESSING JA
MORRIS M
Citation: Ky. Look et al., A PHASE-II TRIAL OF 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN IN RECURRENT EPITHELIAL OVARIAN-CARCINOMA, American journal of clinical oncology, 18(1), 1995, pp. 19-22
Authors:
MUSS HB
Citation: Hb. Muss, CHEMOTHERAPY OF BREAST-CANCER IN THE OLDER PATIENT, Seminars in oncology, 22(1), 1995, pp. 14-16
Authors:
MUSS HB
CASE LD
ATKINS JN
BEARDEN JD
COOPER MR
CRUZ JM
JACKSON DV
OROURKE MA
PAVY MD
POWELL BL
RICHARDS F
SPURR CL
EAGLE K
WHITE DR
Citation: Hb. Muss et al., TAMOXIFEN VERSUS HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE AS INITIAL ENDOCRINE THERAPY FOR PATIENTS WITH METASTATIC BREAST-CANCER - A PIEDMONT-ONCOLOGY-ASSOCIATION STUDY, Journal of clinical oncology, 12(8), 1994, pp. 1630-1638
Authors:
MUSS HB
CASE LD
Citation: Hb. Muss et Ld. Case, TAMOXIFEN VERSUS MEDROXYPROGESTERONE ACETATE FOR METASTATIC BREAST-CANCER - REPLY, Journal of clinical oncology, 12(11), 1994, pp. 2515-2516
Authors:
THOMAS GW
MUSS HB
JACKSON DV
MCCULLOCH J
RAMSEUR W
MCFARLAND J
HOEN H
PAVY M
HEATH R
Citation: Gw. Thomas et al., VINCRISTINE WITH HIGH-DOSE ETOPOSIDE IN ADVANCED BREAST-CANCER - A PHASE-II TRIAL OF THE PIEDMONT-ONCOLOGY-ASSOCIATION, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 165-168
Authors:
ELEY JW
HILL HA
CHEN VW
AUSTIN DF
WESLEY MN
MUSS HB
GREENBERG RS
COATES RJ
CORREA P
REDMOND CK
HUNTER CP
HERMAN AA
KURMAN R
BLACKLOW R
SHAPIRO S
EDWARDS BK
Citation: Jw. Eley et al., RACIAL-DIFFERENCES IN SURVIVAL FROM BREAST-CANCER - RESULTS OF THE NATIONAL-CANCER-INSTITUTE BLACK WHITE CANCER SURVIVAL STUDY/, JAMA, the journal of the American Medical Association, 272(12), 1994, pp. 947-954
Authors:
PERRY JJ
MUSS HB
Citation: Jj. Perry et Hb. Muss, MANAGEMENT OF DISSEMINATED DISEASE IN THE PATIENT WITH BLADDER-CANCER, Urologic clinics of North America, 21(4), 1994, pp. 661-672
Authors:
MUSS HB
Citation: Hb. Muss, CHEMOTHERAPY OF METASTATIC ENDOMETRIAL CANCER, Seminars in oncology, 21(1), 1994, pp. 107-113
Authors:
MUSS HB
Citation: Hb. Muss, C-ERBB-2 EXPRESSION AND RESPONSE TO ADJUVANT THERAPY IN WOMEN WITH NODE-POSITIVE EARLY BREAST-CANCER (VOL 330, 1260, 1994), The New England journal of medicine, 331(3), 1994, pp. 211-211